Drug recall D-0818-2026
Product
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.
Reason for recall
CGMP Deviations
Lots and codes
Lot # NC194068, Exp Date: 10/29/2027.
Recall details
- Recalling firm
- Baxter Healthcare Corporation, Deerfield, IL
- Quantity
- N/A
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 6, 2026
Related products
- Clindamycin phosphate – drug information
- NDC 43066-993 Clindamycin phosphate · Clindamycin Phosphate 600 mg/50mL · Baxter Healthcare Corporation
- NDC 43066-995 Clindamycin phosphate · Clindamycin Phosphate 900 mg/50mL · Baxter Healthcare Corporation